Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.

@article{Morishima2006OnceweeklyEI,
  title={Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.},
  author={Yasuo Morishima and Michinori Ogura and Shuichi Yoneda and Hiroshi Sakai and Kensei Tobinai and Yutaka Nishiwaki and Hironobu Minami and Tomomitsu Hotta and Kohji Ezaki and Yuichiro Ohe and Akira Yokoyama and Masahiro Tsuboi and Kiyoshi Mori and Koshiro Watanabe and Yasuo Ohashi and Kunitake Hirashima and Nagahiro George Saijo},
  journal={Japanese journal of clinical oncology},
  year={2006},
  volume={36 10},
  pages={655-61}
}
OBJECTIVE To determine a recommended dose of once-weekly epoetin-beta administration for anemic cancer patients receiving myelosuppressive chemotherapy, we conducted a multicenter, randomized, double-blind trial. METHODS A total of 86 patients with malignant lymphoma or lung cancer who received chemotherapy containing platinum, taxanes or anthracyclines were enrolled in the study. Patients were randomly assigned into groups that received three dose levels of epoetin-beta (9000, 18,000 or 36… CONTINUE READING